September 2014 Issue of The Ophthalmologist

The Ophthalmologist is one year old. We promised to tell you ophthalmology’s most engaging stories, and we’ve traveled the world to do so.

A new wearable device detects the early signs of diabetic autonomic neuropathy before damaging symptoms appear

Why are certain regions of the choroid more prone to disease than others? To answer that, you need proteomics

Two studies demonstrate the safety and potential of decentered corneal collagen cross linking

An overstretched UK hospital that subcontracted cataract surgery is faced with a 48.3 percent complication rate. Who foots the legal bill?

Can a new implantable microfluidic sensor put IOP tracking in the hands – or rather eyes – of patients with glaucoma?

Are people with certain genotypes actively harmed by AREDS supplementation, accelerating AMD?

Would you recommend vision correction surgery solely to facilitate your patient’s enjoyment of virtual reality technology?

Imagine prescribing eye drops to treat wet AMD, or delivering genes to the retina of patients with retinitis pigmentosa. Nanotechnology can do both – and it could potentially transform ophthalmology

Many astronauts develop eye problems in space. NASA wants to know why, so they’ve established the Vision Impairment and Intracranial Pressure (VIIP) program.

As Second Sight’s Argus II Retinal Prosthesis System nears its 100 patient milestone, we look at how the device has impacted the lives of those implanted

One of the most commonly performed surgical procedures in the world is cataract surgery

One of the legends of refractive surgery talks about his career, his successes and failures, and about the state of ophthalmology today.

Understanding what the Dickens motivates people to consider undergoing an elective ophthalmic procedure will help you guide them to a conclusion that’s right for them

How We Met: Keith Barton and Kuldev Singh

Showcasing the greatest ophthalmic advances of the year